PRO-DEX, INC. Total Liabilities
PRO-DEX, INC. (PDEX) had Total Liabilities of $26.88 million as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-09-03
- 2026-06-30: Liabilities $26.88M.
- 2026-03-31: Liabilities $29.78M.
- 2025-12-31: Liabilities $20.63M.
- 2025-09-30: Liabilities $22.79M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $26.88M 10-K · filed 2026-09-03 | |
| 2026-03-31 | $29.78M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $20.63M 10-Q · filed 2026-01-29 | |
| 2025-09-30 | $22.79M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $24.56M 10-K · filed 2026-09-03 | |
| 2025-03-31 | $28.99M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $28.55M 10-Q · filed 2025-01-30 | |
| 2024-09-30 | $23.43M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $21.61M 10-K · filed 2025-09-04 | |
| 2024-03-31 | $19.61M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $19.64M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $18.39M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $20.23M 10-K · filed 2024-09-05 | |
| 2023-03-31 | $21.79M 10-K · filed 2023-10-13 | $21.14M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $23.64M 10-K · filed 2023-10-13 | $23.11M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $23.55M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $23.66M 10-K · filed 2023-10-13 | |
| 2022-03-31 | $21.61M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $20.11M 10-Q · filed 2022-02-03 | |
| 2021-09-30 | $20.48M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $20.24M 10-K · filed 2022-09-08 | |
| 2021-03-31 | $21.91M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $16.53M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $10.75M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $12.06M 10-K · filed 2021-09-09 | |
| 2020-03-31 | $11.07M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $10.85M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $10.53M 10-Q · filed 2019-11-07 | |
| 2019-07-02 | $3.30M 10-K · filed 2021-09-09 | |
| 2019-07-01 | $3.30M 10-Q · filed 2021-05-06 | |
| 2019-06-30 | $8.51M 10-K · filed 2020-09-10 | |
| 2019-03-31 | $7.98M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $7.04M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $7.47M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.64M 10-K · filed 2019-09-12 | |
| 2018-03-31 | $2.05M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.07M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $1.89M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.64M 10-K · filed 2018-09-13 | |
| 2017-03-31 | $2.43M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $2.83M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $2.80M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $2.27M 10-K · filed 2017-09-14 | |
| 2016-03-31 | $2.38M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $3.40M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $3.91M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $4.04M 10-K · filed 2016-09-15 | |
| 2015-03-31 | $4.21M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $3.06M 10-Q · filed 2015-02-10 | |
| 2014-09-30 | $2.48M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $2.49M 10-K · filed 2015-09-17 | |
| 2014-03-31 | $2.52M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $2.34M 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $2.23M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $2.66M 10-K · filed 2014-09-18 | |
| 2013-03-31 | $2.65M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $2.02M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $3.01M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $3.27M 10-K · filed 2013-09-27 | |
| 2012-03-31 | $4.33M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $4.80M 10-Q · filed 2012-02-07 | |
| 2011-09-30 | $4.53M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $5.24M 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |